Jie Shen
- Cancer Research top 10%
- MicroRNA in disease regulation 7
- Cancer, Hypoxia, and Metabolism 6
-
- Lung Cancer Treatments and Mutations 8
- Neonatal Respiratory Health Research 4
-
- RNA modifications and cancer 5
- Congenital heart defects research 4
- Epidemiology top 10%
- Congenital Heart Disease Studies 8
-
- Rheumatoid Arthritis Research and Therapies 4
- Journals
- Biomedicine & Pharmacotherapy (4 papers)Inhalation Toxicology (4 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jie Shen
64 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 228
- Pulmonary and Respiratory Medicine 322
- Molecular Biology 569
- Epidemiology 251
- Genetics 71
Countries citing papers authored by Jie Shen
This map shows the geographic impact of Jie Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Shen more than expected).
Fields of papers citing papers by Jie Shen
This network shows the impact of papers produced by Jie Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Shen. The network helps show where Jie Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 8 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 8 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 17 | |
| 9 | 2018 | 54 | |
| 10 | 2017 | 14 | |
| 11 | 2015 | 66 | |
| 12 | 2014 | 44 | |
| 13 | Effect of sedation by infusion of dexmedetomidine on inflammatory factors in patients with severe trauma | 2012 | 1 |
| 14 | Comparison of the Sedative Effects of Dexmedetomidine and Midazolam for Critically Ill Patients | 2012 | 2 |
| 15 | 2011 | 0 | |
| 16 | 2011 | 14 | |
| 17 | 2011 | 6 | |
| 18 | 2010 | 26 | |
| 19 | 2009 | 30 | |
| 20 | 2007 | 17 |
About Jie Shen
Jie Shen is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Genetics and Obstetrics and Gynecology, having authored 69 papers that have together received 1.2k indexed citations. Recurring topics across this work include Congenital Heart Disease Studies (8 papers), Lung Cancer Treatments and Mutations (8 papers), MicroRNA in disease regulation (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (5 papers), Neonatal Respiratory Health Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Congenital heart defects research (4 papers). The work is most often cited by research in Cancer Research (228 citations), Pulmonary and Respiratory Medicine (322 citations), Molecular Biology (569 citations), Epidemiology (251 citations) and Genetics (71 citations). Jie Shen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Daikun He, Yiru Shao, Chunbo Li, Keqin Hua, Baohui Han, Wu Bi, Chunnian He, Christine Briggs, Ani Manichaikul and Yong Peng. Their work appears in journals such as Biomedicine & Pharmacotherapy, Inhalation Toxicology, Scientific Reports, Biochemical and Biophysical Research Communications and Toxicology and Industrial Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.